MetaCap

Direxion Daily Healthcare Bull 3X ETF (CURE)

NYSEARCA: CUREDirexion FundsTrading--Leveraged EquityETFUSD

134.15+6.10 (+4.76%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

CURE chart

Full chart

Key facts

Assets (AUM)
$167.54M
Holdings
3
Inception
Jun 15, 2011
Issuer
Direxion Funds
Index tracked
—
Category
Trading--Leveraged Equity
52-week range
82.41 – 150.00
Volume / Avg
51.81K / 57.56K
Beta
—
Previous close
128.05

CURE ETF today

The Direxion Daily Healthcare Bull 3X ETF (CURE) is an exchange-traded fund from Direxion Funds in the Trading--Leveraged Equity category. It charges an expense ratio of 0.94%, or $94.00 per year on a $10,000 investment, and manages $167.5 million in assets. Its largest holding is Eli Lilly and Co (LLY) at 3.22% of assets, and the top 3 positions make up 7.0% of the portfolio out of 3 holdings.

The fund's trailing dividend yield is 0.98% ($0.00 per share annually). CURE launched on Jun 15, 2011.

Summary generated from market data by MetaCap's automated system. Methodology

CURE top 10 holdings

CURE holdings by weight
#HoldingWeight
1LLYEli Lilly and Co3.22%
2JNJJohnson & Johnson2.22%
3ABBVAbbVie Inc1.61%

Top 10 holdings: 7.0% of assets.

CURE performance

1 week

+3.36%

CURE price return, excluding dividends.

ETFs similar to CURE

CURE ETF FAQ

What is the CURE price today?

CURE last traded at $134.15 as of Oct 9, 4:00 PM EDT, up 4.76% on the day.

What is CURE's expense ratio?

CURE has an expense ratio of 0.94%, which works out to about $94.00 per year for every $10,000 invested.

What are CURE's top holdings?

CURE's largest holdings are Eli Lilly and Co (3.22%), Johnson & Johnson (2.22%), AbbVie Inc (1.61%). The top 10 make up 7.0% of the fund.

Does CURE pay a dividend?

Yes. CURE has a trailing dividend yield of 0.98%.

How big is CURE?

CURE has about $167.5 million in assets under management spread across 3 holdings.

Explore